Sale of new drug for diabetes mellitus approved

Published: 2012-06-29 06:59:00

Updated: 2012-06-29 06:59:00

A newly-developed drug for diabetes mellitus has received approval for production and sale from the authorities.

Gemiglo (gemigliptin), developed by LG Life Sciences, has passed safety and effectiveness tests, becoming the 19th new drug developed by a local pharmaceutical company, the Korea Fo...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK